Asie · Agences & temps réel · Focus Taiwan (CNA)

PharmaEssentia seeks to expand access to blood cancer drug in Europe

Publié par Focus Taiwan (CNA) · Taïwan il y a 13 h

Taiwan-based drugmaker PharmaEssentia Corp. is seeking to expand patient access to its blood cancer drug Ropeg in Europe, where the treatment has yet to receive regulatory…

Lire l'article complet sur Focus Taiwan (CNA) Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (focustaiwan.tw)

PharmaEssentia seeks to expand access to blood cancer drug in Europe

À lire aussi

Teodoro cites HADR, other drills as biggest gains of ADMM-Plus

Government optimizes dryland horticulture farming in 13 regions

Five groups of measures underway to manage prices, keep CPI at around 4.5%

Rupee to trade at 94.75-95.75/USD in near term, oil prices to determine movement: BoB Report

Bangladesh deploys additional paramilitary forces as garment workers’ protests continue

European firms find business certainty, reliability at south China's Canton Fair

PharmaEssentia seeks to expand access to blood cancer drug in Europe

Partager

À lire aussi

Teodoro cites HADR, other drills as biggest gains of ADMM-Plus

Government optimizes dryland horticulture farming in 13 regions

Five groups of measures underway to manage prices, keep CPI at around 4.5%

Rupee to trade at 94.75-95.75/USD in near term, oil prices to determine movement: BoB Report

Bangladesh deploys additional paramilitary forces as garment workers’ protests continue

European firms find business certainty, reliability at south China's Canton Fair